Publikationen pro Jahr
Publikationen pro Jahr
- 12 Ergebnisse
Suchergebnisse
-
2022
Cdk5 as a possible new target in biliary tract cancer: preliminary in-situ findings.
Wilhelm, F., Klieser, E., Neumayer, B., Winkelmann, P., Jäger, T., Pachmayr, J., Ardelt, M. A., Huber-Cantonati, P., Ablinger, C., Pancis, I., Ritter, M., Kiesslich, T., Mayr, C. R. & Neureiter, D., 2022.Publikation: Konferenzbeitrag › Abstrakt
-
Deep characterization of the non-alcoholic/alcoholic steatohepatitis in liver specimen demonstrated a specific in-situ immunophenotype: a single center experience.
Neureiter, D., Klieser, E. & Neumayer, B., 2022.Publikation: Konferenzbeitrag › Abstrakt
-
The influence of pancreatic regression characteristics on outcome of neoadjuvant treated pancreatic cancer in two Austrian university centres
Neumayer, B., Neureiter, D., Klieser, E., Huemer, F., Weiss, L., Greil, R., Djanani, A., Oberhuber, G. & Schlick, K., 2022.Publikation: Konferenzbeitrag › Abstrakt
-
2021
HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C. R., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Ritter, M., Jäger, T., Neumayer, Klieser, E. & Neureiter, D., 2021.Publikation: Konferenzbeitrag › Abstrakt
-
HDAC-targeting Epigenetic Drug Screening for Biliary Tract Cancer.
Mayr, C. R. (Erstautor/-in), Kiesslich, T. (Co-Autor/-in), Erber, S. (Co-Autor/-in), Bekric, D. (Co-Autor/-in), Dobias, H. (Co-Autor/-in), Ritter, M. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Winkelmann, P. (Co-Autor/-in), Klieser, E. (Co-Autor/-in) & Neureiter, D. (Letztautor/-in), 2021.Publikation: Konferenzbeitrag › Abstrakt
-
PRGS and in-situ immunophenotype as a combined „tool“ for monitoring the therapeutical efficiency of PIPAC in different peritoneal cancer diseases: a single centre experience.
Neureiter, D., Klieser, E., Neumayer, B., Gruber, R., Ramspott, J., Schredl, P., Emmanuel, K. & Jäger, T., 2021.Publikation: Konferenzbeitrag › Abstrakt
-
2017
Expression pattern of histone deacetylases in gastrointestinal stromal tumors compared to clinic-pathological data
Klieser, E., Schmidt, J., Jäger, T., Mayr, C. R., Urbas, R., Kiesslich, T. & Neureiter, D., 2017.Publikation: Konferenzbeitrag › Abstrakt
-
T-cell immune response: a prognostic factor for pathological regression in previously adjuvant treated colorectal cancer liver metastasis
Klieser, E., Krenn, P., Urbas, R., Primavesi, Sotlar, K., Neureiter, D. & Hartmann, T., 2017.Publikation: Konferenzbeitrag › Abstrakt
-
T-cell immune response: a prognostic factor for pathological regression in previously adjuvant treated colorectal cancer liver metastasis
Klieser, E., Krenn, P., Urbas, R., Primavesi, Sotlar, K., Neureiter, D. & Hartmann, T., 2017.Publikation: Konferenzbeitrag › Abstrakt
-
2016
New macroscopically and microscopically aspects improving evaluation of tumor regression grading of neo-adjuvant treated rectal cancer.
Urbas, R., Klieser, E., Jäger, T., Dinnewitzer, A. & Neureiter, D., 2016.Publikation: Konferenzbeitrag › Abstrakt
-
2015
Epidemiomlogical and clinic-pathological survey of patients with autoimmune diseases of the liver in Austrian Federal State Salzburg: Experience of a single center.
Illig, R., Klieser, E., Tränkenschuh, W., Kiesslich, T., Berr, F. & Neureiter, D., 2015.Publikation: Konferenzbeitrag › Abstrakt
-
2014
Expression pattern of epithelial-mesenchymal-transition associated miRNAs in biliary tract cancer: a clinical and pathological approach.
Illig, R., Kiesslich, T., Kemmerling, R., Klieser, E., Berr, F. & Neureiter, D., 2014.Publikation: Konferenzbeitrag › Abstrakt